PTEN and metastatic melanoma: Our immunohistochemical data contrast to the report of Zhou et al (2000) who described absent or weak expression of PTEN/MMAC1 nuclear signals in four primary and 30 metastatic melanomas and assumed epigenetic PTEN/MMAC1 silencing.